Tamiflu News and Research

RSS
NanoViricides, LRRI sign NDA for IND-enabling efficacy studies on FluCide drug candidates

NanoViricides, LRRI sign NDA for IND-enabling efficacy studies on FluCide drug candidates

Some strains of avian H7N9 influenza develop resistance to antiviral drugs

Some strains of avian H7N9 influenza develop resistance to antiviral drugs

New paper analytical devices can screen fake antimalarial drugs

New paper analytical devices can screen fake antimalarial drugs

Romark Laboratories starts NT-300 Phase 3 trial for treatment of acute uncomplicated influenza

Romark Laboratories starts NT-300 Phase 3 trial for treatment of acute uncomplicated influenza

New assays are effective in managing patients with influenza virus infection

New assays are effective in managing patients with influenza virus infection

Study: Half of Tamiflu prescriptions during 2009-10 influenza pandemic went unused in England

Study: Half of Tamiflu prescriptions during 2009-10 influenza pandemic went unused in England

Reports of H7N9 cases, deaths continue from across China

Reports of H7N9 cases, deaths continue from across China

Influenza drug: an interview with Dr Jenny McKimm-Breschkin, CSIRO

Influenza drug: an interview with Dr Jenny McKimm-Breschkin, CSIRO

Researchers identify new function for matriptase enzyme

Researchers identify new function for matriptase enzyme

91 charged with $430 million Medicare billing fraud

91 charged with $430 million Medicare billing fraud

NanoViricides’ oral FluCide dramatically improves survival in animals with H3N2 influenza A

NanoViricides’ oral FluCide dramatically improves survival in animals with H3N2 influenza A

Strong antiviral antibody response observed in oral administration of Flucide

Strong antiviral antibody response observed in oral administration of Flucide

Oral FluCide drug candidates effective in reducing lung viral load: NanoViricides

Oral FluCide drug candidates effective in reducing lung viral load: NanoViricides

Gilead Sciences second quarter total revenues increase 13% to $2.41 billion

Gilead Sciences second quarter total revenues increase 13% to $2.41 billion

WSU researcher looks for clues on link between H1N1 flu and obesity

WSU researcher looks for clues on link between H1N1 flu and obesity

GPUs simulate molecular processes during swine flu drug treatment

GPUs simulate molecular processes during swine flu drug treatment

One of the controversial avian flu studies published in full finally

One of the controversial avian flu studies published in full finally

Flu outbreak at veterans home

Flu outbreak at veterans home

Counterfeit drugs on the Internet find their way into legitimate pharmacies

Counterfeit drugs on the Internet find their way into legitimate pharmacies